[PDF] Cost Containment And The Pharmaceutical Industry eBook

Cost Containment And The Pharmaceutical Industry Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Cost Containment And The Pharmaceutical Industry book. This book definitely worth reading, it is an incredibly well-written.

Drugs and Money

Author : Maurice Nelson Graham Dukes
Publisher : IOS Press
Page : 164 pages
File Size : 42,82 MB
Release : 2003
Category : Drugs
ISBN : 9781586033347

GET BOOK

This edition aims to provide policy makers and regulators with a compact and practical review of the various approaches that have been developed and tested to date in an effort to contain the overall costs of pharmaceutical services and drug treatment.

Health-care Cost Containment

Author : Bernstein Research
Publisher :
Page : 178 pages
File Size : 23,51 MB
Release : 1993
Category : Medical care, Cost of
ISBN :

GET BOOK

Medicine Price Surveys, Analyses and Comparisons

Author : Sabine Vogler
Publisher : Academic Press
Page : 490 pages
File Size : 26,71 MB
Release : 2018-10-23
Category : Business & Economics
ISBN : 0128132124

GET BOOK

Medicine Price Surveys, Analyses and Comparisons establishes guidelines for the study and implementation of pharmaceutical price surveys, analyses, and comparisons. Its contributors evaluate price survey literature, discuss the accessibility and reliability of data sources, and provide a checklist and training kit on conducting price surveys, analyses, and comparisons. Their investigations survey price studies while accounting for the effects of methodologies and explaining regional differences in medicine prices. They also consider policy objectives such as affordable access to medicines and cost-containment as well as options for improving the effectiveness of policies. Provides guidance for planning and implementing pharmaceutical pricing policies and systems Reviews external price referencing systems Explains common baselines for interpreting price surveys Defines pharmaceutical price terminology and nomenclature

Making Medicines Affordable

Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 235 pages
File Size : 48,5 MB
Release : 2018-03-01
Category : Medical
ISBN : 0309468086

GET BOOK

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Medical Innovation in the Changing Healthcare Marketplace

Author : National Research Council
Publisher : National Academies Press
Page : 92 pages
File Size : 21,14 MB
Release : 2002-05-06
Category : Medical
ISBN : 0309183014

GET BOOK

A wave of new health care innovation and growing demand for health care, coupled with uncertain productivity improvements, could severely challenge efforts to control future health care costs. A committee of the National Research Council and the Institute of Medicine organized a conference to examine key health care trends and their impact on medical innovation. The conference addressed the following question: In an environment of renewed concern about rising health care costs, where can public policy stimulate or remove disincentives to the development, adoption and diffusion of high-value innovation in diagnostics, therapeutics, and devices?

Assuring the Quality of Health Care in the European Union

Author : Helena Legido-Quigley
Publisher : World Health Organization
Page : 242 pages
File Size : 40,5 MB
Release : 2008
Category : Medical
ISBN : 9289071931

GET BOOK

People have always travelled within Europe for work and leisure, although never before with the current intensity. Now, however, they are travelling for many other reasons, including the quest for key services such as health care. Whatever the reason for travelling, one question they ask is "If I fall ill, will the health care I receive be of a high standard?" This book examines, for the first time, the systems that have been put in place in all of the European Union's 27 Member States. The picture it paints is mixed. Some have well developed systems, setting standards based on the best available evidence, monitoring the care provided, and taking action where it falls short. Others need to overcome significant obstacles.